[PDF][PDF] Intratumoral injection of rhenium-188 microspheres into an animal model of hepatoma

SJ Wang, WY Lin, MN Chen, CS Chi… - Journal of Nuclear …, 1998 - Soc Nuclear Med
MATERIALS AND METhODS Rhenium-188 Production Rhenium-188 was obtained from an
alumina-based †88W/'88Re generator. Tunsten-l88 was supplied by the Oak Ridge …

Use of the Oak Ridge National Laboratory tungsten-188/rhenium-188 generator for preparation of the rhenium-188 HDD/lipiodol complex for trans-arterial liver cancer …

JM Jeong, FFR Knapp Jr - Seminars in nuclear medicine, 2008 - Elsevier
This work describes the installation, use, and quality control (QC) of the alumina-based
tungsten-188/rhenium-188 (188Re) generators provided by the Oak Ridge National …

Issues associated with the use of the Tungsten-188/Rhenium188 generator and concentrator system and preparation of Re-188 HDD: A report

FF Knapp Jr, JH Turner, JM Jeong… - World Journal of Nuclear …, 2004 - inis.iaea.org
[en] The ready availability of no-carrier-added Rhenium-188 from the Tungsten-
188/Rhenium-188 generator represents an important source of a therapeutic radioisotope …

Rhenium-188 for therapeutic applications from an alumina-based tungsten-188/rhenium-188 radionuclide generator. A radionuclide generator system based on the …

AP Callahan, DE Rice, FF Knapp Jr - Nuc Compact, Compact News Nucl …, 1989 - osti.gov
The performance of a new tungsten-188/rhenium-188 (/sup 188/W//sup 188/Re)
radionuclide generator system utilizing tungsten-188 loaded as sodium or potassium …

Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer …

FF Knapp Jr, AL Beets, S Guhlke, PO Zamora… - Anticancer …, 1997 - europepmc.org
Rhenium-188 (beta-= 2.2 MeV; gamma= 155 keV; T1/2 16.9 hours) is an attractive
therapeutic radioisotope which is produced from decay of the reactor-produced tungsten …

A report on the implementation aspects of the international atomic energy agency's first doctoral coordinated research project,“management of liver cancer using …

AK Padhy, M Dondi - Seminars in nuclear medicine, 2008 - Elsevier
Liver cancer is one of the most dreaded cancers, and it is highly prevalent in the developing
countries, where the resources are extremely scarce to deal with this disease using the …

Rhenium-188-A generator-derived radioisotope for cancer therapy

FF Knapp Jr - Cancer biotherapy & radiopharmaceuticals, 1998 - liebertpub.com
Rhenium-l88 (188Re) is an important therapeutic radioisotope which is obtained on demand
as carrier-free sodium perrhenate by saline elution of the tungsten-188/rhenium-188 …

Rhenium-188 based radiopharmaceuticals for treatment of liver tumours

B Lambert, K Bacher… - The Quarterly Journal of …, 2009 - search.proquest.com
Abstract Rhenium-188 (^ sup 188^ Re) is a high energy beta-emitter with a physical half life
of 17 hours. Various^ sup 188^ Re based radiopharmaceuticals were developed to treat …

[188Re] rhenium sulfide suspension: a potential radiopharmaceutical for tumor treatment following intra-tumor injection

Y Junfeng, Y Duanzhi, M Xiaofeng, G Zili… - Nuclear medicine and …, 1999 - Elsevier
Intralesional therapy has been shown to be an effective treatment for tumors. In this study,
the suitability of [188Re] rhenium sulfide suspension for tumor treatment following intra …

Effect of stoichiometric and preparation parameters on W-188/Re-188 gel generator performance

Q Liang, GJ Ehrhardt, AR Ketring, R Miller - Radiochimica Acta, 1997 - degruyter.com
Rhenium-188 is attractive for pre-targeted radioimmunotherapy because of its 17 hour half
life, energetic beta emission, and availability from a generator. Gel-type W-188/Re-188 …